CEPHEID (NASDAQ:CPHD) : Wednesdays money flow analysis of CEPHEID (NASDAQ:CPHD) indicates the selling of stock on the strength of price. The investors sold the stock on every rise as seen in the downtick transactions of $3.59 million. In comparison, the inflow of money on upticks was a meager $1.13 million. The dollar value of composite uptick trades minus the downtick trades was negative $2.46 million. The uptick to downtick ratio of 0.32 in the money flow shows weakness. The downtick transaction value was high at $2.39 million, which denotes distribution on strength.. Hence, the net money flow in the stock was negative ($2.39 million). CEPHEID (NASDAQ:CPHD) gained $0.26 at $29.1, a change of 0.9% over the previous days close.
In an insider trading activity,The officer (Corporate VP & CRO) of Cepheid, Campbell Scott A. sold 2,058 shares at $27.9 on May 3, 2016. The Insider selling transaction had a total value worth of $57,418. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. Currently the company Insiders own 4.16% of CEPHEID shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -9.06% . Institutional Investors own 95.36% of CEPHEID shares. During last six month period, the net percent change held by insiders has seen a change of -10.42%.
The company shares have dropped -52.82% from its 1 Year high price. On Jul 20, 2015, the shares registered one year high at $63.69 and the one year low was seen on May 6, 2016. The 50-Day Moving Average price is $28.07 and the 200 Day Moving Average price is recorded at $31.20. CEPHEID (NASDAQ:CPHD): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $29.26 and $28.79 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $29.61. The buying momentum continued till the end and the stock did not give up its gains. It closed at $29.55, notching a gain of 2.46% for the day. The total traded volume was 649,152 . The stock had closed at $28.84 on the previous day.
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the clinical market and non-clinical markets. Its systems enable molecular testing for organisms and genetic-based diseases. Molecular testing involves various time-intensive steps, including sample preparation, DNA amplification and detection. The Companys systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to DNA amplification and detection, serves reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.